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Preventive and curative effects of anti- NGF blocking antibodies in ex-
perimental pulmonary hypertension
Véronique Freund- Michel [Orateur] (1), Christian Toussaint (2), Mathilde 
Dubois (1), Arnaud Courtois (1), Roger Marthan (1), Jean- Pierre 
Savineau (1), Bernard Muller (1)
(1) Université Bordeaux Segalen, INSERM U1045, Bordeaux Cedex, France 
- (2) Université Bordeaux Segalen, Bordeaux Cedex, France
Introduction: We have previously shown that expression of NGF and of 
its receptors is increased is both experimental and human pulmonary hyper-
tension (PH). In vitro/ex vivo, we have also shown the ability of exogenous 
NGF to participate to inÀ ammation, altered pulmonary vascular reactivity 
and remodelling, three major features in this disease. We have here studied 
whether administration of anti- NGF blocking antibodies in vivo may have pre-
ventive and/or curative effects in PH rat models.
Methods: Experimental PH in the rat was induced either by a single injec-
tion of monocrotaline (MCT, day (D)1, 60mg/kg), or after 28 days of chronic 
hypoxia (CH, 0.5 atm). When used as a preventive treatment, anti- NGF bloc-
king antibodies (10g/kg ip) were administered at D0- 2- 7 for MCT or at 
D1- 8- 15- 22 for CH. When used as a curative treatment, antibodies were admi-
nistered at D15- 19- 22- 26 for both MCT and CH. Pulmonary arterial pressure 
(Pap) and Fulton index were assessed at D28. Secretion of interleukin- 1β (IL- 
1β) and tumor necrosis factor- α (TNF- α) from rat pulmonary arteries (PA) 
was assessed by ELISA. PA reactivity to prostaglandin F2α (PGF2α) or phe-
nylephrine was assessed ex vivo. PA medial wall thickness was evaluated on 
lung sections after hematoxylin and eosin staining.
Results: In both MCT and CH rats, anti- NGF blocking antibodies displayed 
preventive as well as curative effects. Pap, Fulton index, cytokine secretion, 
hyperreactivity to phenylephrine or PGF2α and PA medial wall thickness were 
all signi¿ cantly reduced.
Conclusion: We show here that administration of anti- NGF blocking anti-
bodies in vivo can, at least partially, both prevent and reverse experimental PH 
in the rat. Together with our previous results observed in particular in human 
tissues, the present study con¿ rms an important role of NGF in pulmonary 
hypertension.
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Improvement of right ventricular function in patients with pulmonary 
arterial hypertension treated with vasodilator therapy. A prospective 
2D strain study
Quentin Landolff [Orateur], Baptiste Kurtz, Charlotte Vallet, Nathanaël 
Auquier, Dimitri Stepowski, Bertrand D’Héré, Stéphane Dominique, 
Hélène Eltchaninoff, Fabrice Bauer
Hôpital Charles Nicolle, Rouen, France
Background: Dedicated drugs improve functional status and hemodynamic 
in patients with pulmonary hypertension. Whether these results can be trans-
lated into an echocardiographic improvement of right ventricular function has 
yet to be demonstrated. 
 Methods and Results: 23 symptomatic patients receiving the de¿ nition 
of pulmonary arterial hypertension (PAH) were treated by phosphodiesterase 
type 5 inhibitors (26%), endothelin receptor antagonists (31%) or both (43%). 
Right heart catheterization and echocardiography were performed before and 
after 1 year of treatment for invasive measurement, right cavities area by pla-
nimetry, tricuspid anterior plan systolic excursion (TAPSE) by m- mode, lon-
gitudinal peak S velocity by tissue Doppler imaging and right ventricular 
longitudinal peak systolic 2D strain. 
Results: There were 10 men. Mean age was 55±19 y. All were in NYHA 
functional class 3 or greater. Pulmonary vascular resistances (7.2±5.2 vs. 
4.4±2.4 dyn•s•cmí5, p=0.016) and cardiac index (3.0±0.9 vs. 3.9±1.2 l/min/
m², p=0.003) were improved at 1 year follow- up. Echocardiographic ¿ n-
dings after 1 year of treatment shows right ventricular cavities area reduction, 
increased longitudinal 2D strain (13.5±5.6 vs. 17.5±6.4, p=0.002) while longi-
tudinal velocity (11.1±3.7 vs.11.8±3.6m/s, p=0.67) and TAPSE (16.4±3.6 vs. 
19.3±6.8, p=0.07) were unchanged. 
Conclusion: These results suggest 2D strain right ventricular function 
improvement in patients receiving oral vasodilator therapy for pulmonary arte-
rial hypertension.
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Stretch- activated Channels are coupled to Ryanodine Receptors in In-
trapulmonary Arterial Smooth Muscle Cells. Modi¿ cations in Pulmo-
nary Hypertension
Guillaume Gilbert [Orateur], Jean- Pierre Savineau, Jean- François Quignard
Université Bordeaux Segalen, CRCTB - INSERM U1045, Bordeaux, France
Stretching the plasma membrane of pulmonary arterial smooth muscle cells 
(PASMC) provokes their contraction by a rise of intracellular calcium concen-
tration ([Ca2+]i). This mechanism called myogenic tone involves Ca2+ per-
meable stretch- activated channels (SAC) in PASMC. The aim of this study 
was to characterize the Ca2+ signaling pathways induced by a stretch of the 
membrane of freshly isolated PASMC from normal rats and rats with a pul-
monary hypertension where the myogenic tone is stronger.
Pulmonary hypertension was induced by a chronic hypoxia of rats in a 
hypobaric chamber. The SAC activity was assayed by patch- clamp after a 
stretch of the membrane via a patch- clamp pipette or by an osmotic shock. 
Simultaneously, [Ca2+]i was measured with the indo- 1 probe. Finally, with a 
pharmacological approach and immunocytochemistry, the roles of intracellular 
calcium stores have been studied.
We showed that a stretch of PASMC membrane induces a rise of [Ca2+]
i due to a Ca2+ inÀ ux through SAC, ampli¿ ed by two mechanisms: (1) ¿ rst 
the Ca2+ entry activates KCa channels that hyperpolarize the cell and contri-
butes to the Ca2+ entry by increasing its electrochemical gradient; (2) the Ca2+ 
entry through SAC is ampli¿ ed by a Ca2+- induced calcium- release mechanism 
with ryanodine receptor 1 (RyR- 1) located in the sarcoplasmic reticulum (SR) 
under the plasma membrane. Besides, this SR is re¿ lled by SERCA2b pumps.
In PASMC from rats with pulmonary hypertension, those phenomena are 
ampli¿ ed with: (1) a stronger Ca2+ inÀ ux through SAC; (2) a more important 
ampli¿ cation of this inÀ ux by RyR- 1 and RyR- 3. Furthermore, in absence 
of extracellular Ca2+, a stretch of the membrane induces a [Ca2+]i rise by 
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[Ca2+ i increase and, in ¿ ne, in a stronger myogenic tone. This study sug-
gests that SAC and SR calcium stores are implicated in hyper- responsiveness 
of the pulmonary artery that occurs in pulmonary hypertension.
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DHA- monoacylglyceride decreases endothelin- 1 induced calcium sensi-
tivity and proliferation in human pulmonary arteries.
Eric Rousseau [Orateur] (1), Caroline Morin (1), Samuel Fortin (2)
(1) Université de Sherbrooke, Physiologie, FMSS, Sherbrooke, Canada - 
(2) SCF- Pharma, Rimouski, Canada
Pulmonary artery vasoconstriction and vascular remodelling contribute 
to a sustained elevation of pulmonary vascular resistance and pressure in 
patients with pulmonary arterial hypertension (PH), an often fatal hemody-
namic disease. The effect of DHA monoacylglyceride (MAG- DHA) and the 
role of the protein kinase C- potentiated inhibitor protein of 17 kDa (CPI- 17) 
were determined on vasoconstriction and smooth muscle cell proliferation of 
human pulmonary arteries (HPA). HPA were obtained from 16 patients under-
going lung resection for carcinoma. The mechanical tension and Ca2+ sensiti-
vity were measured on arterial rings treated with Endothelin- 1 (ET- 1) in the 
absence or presence of MAG- DHA. The effect of MAG- DHA on prolifera-
tion level of smooth muscle cells isolated from HPA was evaluated in order to 
determine the role of CPI- 17 protein. MAG- DHA treatment decreased the reac-
tivity and Ca2+ sensitivity induced by ET- 1 in HPA. MAG- DHA treatment also 
decreased the expression of vascular endothelial growth factor (VEGF) induced 
by ET- 1. Moreover, both VEGF inhibitor and MAG- DHA treatments reduced 
Ca2+ hypersensitivity induced by ET- 1, which was associated to a reduction in 
CPI- 17 and MYPT- 1 phosphorylation levels. Proliferation of ET- 1–stimulated 
human pulmonary artery smooth muscle cells (PASMc) was also decreased fol-
lowing CPI- 17 siRNA transfection and MAG- DHA treatments. Western blot 
analyses revealed that MAG- DHA treatment resulted in decreased phospho-
rylation levels of CPI- 17 and ERK in PASMc treated with ET- 1. 
We have demonstrated that VEGF interacted with CPI- 17 signaling pathway 
resulting in an increase in Ca2+ sensitivity and proliferation of PASMc, while 
MAG- DHA treatment reversed these effects.
0333
Study of a new index in pulmonary arterial hypertension: the index of 
tricuspid displacement
Cherine Benzouid [Orateur] (1), Pierre Cerboni (2), Pamela Moceri (2)
(1) CHU Timone enfant, cardiologie pédiatrique, Marseille, France - 
(2) CHU Pasteur Nice, cardiologie, Nice, France
Introduction: This study intends to demonstrate the value of a new 
index, the index of tricuspid displacement (IDT), as measured by the ratio 
of ITVS at the lateral tricuspid annulus and the distance between it and the 
tip of the RV. The aim of this work is to de¿ ne a standard for the IDT and 
to correlate it with prognosis parameters of PAH, as well as indices of RV 
function.
Method: 66 patients included: 32 cases with PAH and 34 controls. An 
echocardiogram was performed for each of them and a BNP’s measurement 
within 6 hours. We precised the importance of symptoms by NYHA func-
tional stage.
Results: The two groups are statistically comparable concerning the cri-
teria of age, sex, BMI and left ¿ lling pressures (by E/Ea mitral). They are 
signi¿ cantly different on the other indices. The values of the IDT are lower 
in cases compared with controls (respectively: 0.21 vs 0.36 (p<0.001). 
The correlation of this new index is good with TAPSE, peak of S, ITVS, 
and with POD (r respectively: 0.5, 0.6, 0.9, 0.65). We also note that the 
median of the IDT is signi¿ cantly lower in patients with effusion compared 
to those without pericardial effusion: 0.187 vs. 0.253 (p<0.001). The cor-
relation of our index, although not signi¿ cant with the BNP, the Tei, SOD, 
the FRSVD and cardiac index (r respectively: 0.30, 0.32, 0.2, 0.34, 0.25), 
remains better compared to the peak of the S wave with the same parame-
ters (r respectively: 0.19, 0.28, 0.16, 0.33, 0.26). Moreover, a threshold of 
IDT to 0.27 predicts a BNP>180 with good sensitivity, speci¿ city and AUC, 
while a threshold of 0.19 identi¿ es the most serious patients in stage IV of 
the NYHA. ROC curves show poorer results for the peak of the S wave with 
the same cutoff of BNP and also to predict the most serious patients with 
NYHA IV.
Conclusion: The index of tricuspid displacement showed encouraging 
results in terms of
ź
